BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 23645660)

  • 1. Long-Smoldering T-prolymphocytic Leukemia: A Case Report and a Review of the Literature.
    Gjelberg HK; Helgeland L; Liseth K; Micci F; Sandnes M; Russnes HG; Reikvam H
    Curr Oncol; 2023 Nov; 30(11):10007-10018. PubMed ID: 37999147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T-Cell Prolymphocytic Leukemia With t(X;14)(q28;q11.2): A Clinicopathologic Study of 15 Cases.
    Hu Z; Medeiros LJ; Xu M; Yuan J; Peker D; Shao L; Tang Z; Mai B; Thakral B; Rios A; Hu S; Wang W
    Am J Clin Pathol; 2023 Apr; 159(4):325-336. PubMed ID: 36883805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the understanding and management of T-cell prolymphocytic leukemia.
    Laribi K; Lemaire P; Sandrini J; Baugier de Materre A
    Oncotarget; 2017 Nov; 8(61):104664-104686. PubMed ID: 29262669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell prolymphocytic leukaemia associated with immune checkpoint inhibitor (pembrolizumab).
    Avelino AR; Elmanaseer O; Wrzesinski S; Raval M
    BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35351740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed Diagnosis of T-Cell Prolymphocytic Leukemia: Approach to Chronic Lymphocytosis.
    Geres H; Krishnan N; Kotchetkov R
    Case Rep Oncol; 2023; 16(1):568-576. PubMed ID: 37900812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AGO2 in T-prolymphocytic leukemia: its canonical and non-canonical deregulation and function.
    Braun T; Klepzig H; Herling M
    Oncotarget; 2023 May; 14():395-397. PubMed ID: 37141408
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical analysis of prolymphoblastic leukemia: the rare hematological malignancy in the elderly.
    Yan Z; Zeng M; Chen X; Yin Y; Liu Y
    Am J Transl Res; 2023; 15(9):5653-5663. PubMed ID: 37854229
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolymphocytic Leukaemia: an Update on Biology and Treatment.
    El-Sharkawi D; Dearden C
    Curr Oncol Rep; 2024 Feb; 26(2):129-135. PubMed ID: 38214879
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic hematopoietic stem cell transplantation for T-prolymphocytic leukemia: a report from the French society for stem cell transplantation (SFGM-TC).
    Guillaume T; Beguin Y; Tabrizi R; Nguyen S; Blaise D; Deconinck E; Redjoul R; Cornillon J; Guillerm G; Contentin N; Sirvent A; Turlure P; Salmon A; Huynh A; François S; Peffault de Latour R; Yakoub-Agha I; Mohty M
    Eur J Haematol; 2015 Mar; 94(3):265-9. PubMed ID: 25130897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell Prolymphocytic Leukemia.
    Sud A; Dearden C
    Hematol Oncol Clin North Am; 2017 Apr; 31(2):273-283. PubMed ID: 28340878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolymphocytic Leukemia: New Insights in Diagnosis and in Treatment.
    Collignon A; Wanquet A; Maitre E; Cornet E; Troussard X; Aurran-Schleinitz T
    Curr Oncol Rep; 2017 Apr; 19(4):29. PubMed ID: 28324286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of cytogenetic abnormalities in T-cell prolymphocytic leukemia.
    Hu Z; Medeiros LJ; Fang L; Sun Y; Tang Z; Tang G; Sun T; Quesada AE; Hu S; Wang SA; Pei L; Lu X
    Am J Hematol; 2017 May; 92(5):441-447. PubMed ID: 28194886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of prolymphocytic leukemia.
    Dearden C
    Hematology Am Soc Hematol Educ Program; 2015; 2015():361-7. PubMed ID: 26637744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia.
    Kiel MJ; Velusamy T; Rolland D; Sahasrabuddhe AA; Chung F; Bailey NG; Schrader A; Li B; Li JZ; Ozel AB; Betz BL; Miranda RN; Medeiros LJ; Zhao L; Herling M; Lim MS; Elenitoba-Johnson KS
    Blood; 2014 Aug; 124(9):1460-72. PubMed ID: 24825865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinically silent indolent T-cell leukemia.
    Janot C; Feriel J; Borie C; Lefevre E; Bennaceur-Griscelli A; Turhan AG; Aumont C
    Clin Case Rep; 2019 Jan; 7(1):24-26. PubMed ID: 30656001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring the molecular pathogenesis associated with T-cell prolymphocytic leukemia based on a comprehensive bioinformatics analysis.
    Shi Z; Yu J; Shao H; Cheng K; Zhai J; Jiang Q; Li H
    Oncol Lett; 2018 Jul; 16(1):301-307. PubMed ID: 29928415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A patient with white blood cell counts more than a million: A diagnostic and therapeutic challenge.
    Figueroa-Jiménez LA; Cabrera-Márquez AL; Báez-Díaz L; Cáceres-Perkins W
    Bisturi (S Juan); 2016; 2016():12-16. PubMed ID: 29238632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell prolymphocytic leukaemia (T-PLL): a rare disease with a grave prognosis.
    Vivekanandarajah A; Atallah JP; Gupta S
    BMJ Case Rep; 2013 May; 2013():. PubMed ID: 23645660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case report of T cell prolymphocytic leukemia and Kaposi sarcoma and a review of T cell prolymphocytic leukemia.
    Paul RN; Alizadeh L; Ajayi OI; Karpurapu H; Ganesan C; Taddesse-Heath L; Aggarwal A
    Acta Haematol; 2012; 127(4):235-43. PubMed ID: 22517037
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.